TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17189793

Group type: EXPERIMENTAL
Intervention: Nepafenac ophthalmic suspension 0.1%
Number of subjects: 476

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 476
Study: 15343260

Group type: EXPERIMENTAL
Intervention: Amniotic Fluid Index (AFI)
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Single Deepest Pocket (2 x 1 pocket)
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: AFI
Number of subjects: 1080

Group type: COMPARATOR
Intervention: 2 x 1 pocket
Number of subjects: 1080
Study: 11585118

Group type: EXPERIMENTAL
Intervention: Flap surgery plus EMD
Number of subjects: 16

Group type: COMPARATOR
Intervention: Flap surgery plus placebo
Number of subjects: 16
Study: 9615303

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy for 12 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 8074426

Group type: EXPERIMENTAL
Intervention: Bisoprolol (10 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Celiprolol (200 mg/day)
Number of subjects: 80
Study: 2684023

Group type: EXPERIMENTAL
Intervention: Terbinafine 500 mg daily for 6 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Griseofulvin 500 mg daily for 6 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Griseofulvin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Terbinafine
Number of subjects: 50
Study: 1097740

Group type: EXPERIMENTAL
Intervention: 15 mg oral medrogestone twice daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 7.5 mg oral medrogestone twice daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 19
Study: 29789445

Group type: EXPERIMENTAL
Intervention: KMC with woolen cap (CAP group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: KMC without woolen cap (NOCAP group)
Number of subjects: 300
Study: 28939427

Group type: EXPERIMENTAL
Intervention: Injection of bacterial endotoxin lipopolysaccharide (LPS) at a dose of 2ng/kg body weight
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Injection of bacterial endotoxin lipopolysaccharide (LPS)
Number of subjects: 22
Study: 26643919

Group type: EXPERIMENTAL
Intervention: Fortaleça sua Saúde program (intervention)
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1085
Study: 23634717

Group type: EXPERIMENTAL
Intervention: Purse-string suture (PSS)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Direct suture (DS)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 84
Study: 21415778

Group type: COMPARATOR
Intervention: Gefitinib 250 mg daily alone (G)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Gefitinib plus daily oral UFT (GU)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Gefitinib plus UFT
Number of subjects: 115
Study: 18316792

Group type: EXPERIMENTAL
Intervention: Docetaxel (DOC) 75 mg/m² IV every 14 days for four cycles followed by doxorubicin 60 mg/m² and cyclophosphamide 600 mg/m² (AC) IV every 14 days for four cycles
Number of subjects: 56

Group type: COMPARATOR
Intervention: Doxorubicin 60 mg/m² and cyclophosphamide 600 mg/m² (AC) IV every 14 days for four cycles followed by Docetaxel (DOC) 75 mg/m² IV every 14 days for four cycles
Number of subjects: 56
Study: 17159108

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D 4,000 IU/day (adults)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Low-dose vitamin D 400 IU/day (adults)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Low-dose vitamin D 2,000 IU/day (children/adolescents)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D 2,000 IU/day (children/adolescents)
Number of subjects: 150
Study: 15251831

Group type: EXPERIMENTAL
Intervention: D‐chiro‐inositol 600 mg orally once daily for 6 to 8 weeks
Number of subjects: 20
Study: 10613558

Group type: EXPERIMENTAL
Intervention: Endoscopic saphenous vein harvesting (MIVH)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Conventional open technique
Number of subjects: 103
Study: 7736741

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 20
Study: 2292637

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Pharmacotherapy only (NoCT)
Number of subjects: 64
Study: 7375893

Group type: EXPERIMENTAL
Intervention: Björk-Shiley (B-S) valve
Number of subjects: 300

Group type: COMPARATOR
Intervention: Lillehei-Kaster (L-K) valve
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Further 9 patients
Number of subjects: 300
Study: 30888253

Group type: EXPERIMENTAL
Intervention: Zinc (50 mg)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Selenium (200 µg)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 30265431

Group type: EXPERIMENTAL
Intervention: Intracoronary hypothermia (saline at 4°C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no hypothermia)
Number of subjects: 60
Study: 27148802

Group type: EXPERIMENTAL
Intervention: ADRCs (40-million, n=28; 80-million, n=3)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ADRCs
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 26276138

Group type: EXPERIMENTAL
Intervention: Government Midwifery Incentive Scheme (GMIS)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Other interventions to improve access to essential maternal health services
Number of subjects: 180

Group type: COMPARATOR
Intervention: Traditional birth attendants
Number of subjects: 180
Study: 23855503

Group type: EXPERIMENTAL
Intervention: AFXL-PDT
Number of subjects: 10

Group type: COMPARATOR
Intervention: AFXL
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Overall assessment
Number of subjects: 10
Study: 21767584

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 18309606

Group type: EXPERIMENTAL
Intervention: Mechanical and thermal cycling (20,000 cycles under 10 N load, immersion in distilled water at 37 degrees C, and thermocycled 3,000 cycles between 5-55 degrees C)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (specimens tested without aging, only water storage at 37 degrees C for 24 hours)
Number of subjects: 84
Study: 16580448

Group type: EXPERIMENTAL
Intervention: Stentless bioprostheses (Medtronic Freestyle)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Stented bioprostheses (Medtronic Mosaic)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 14641691

Group type: EXPERIMENTAL
Intervention: 300 micro g nasal 17beta‐estradiol
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 11053333

Group type: EXPERIMENTAL
Intervention: L-NMMA after exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: L-NMMA after sham
Number of subjects: 8
Study: 9209787

Group type: EXPERIMENTAL
Intervention: Ceftibuten (400 mg daily)
Number of subjects: 443

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (AMX/CA, 500 mg/125 mg three times daily)
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Ceftibuten (once-daily)
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Ceftibuten (twice-daily)
Number of subjects: 443
Study: 7963779

Group type: EXPERIMENTAL
Intervention: Clonidine 0.150 mg i.v.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Meperidine 50 mg i.v.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 60
Study: 3308829

Group type: EXPERIMENTAL
Intervention: fenfluramine
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 31501493

Group type: EXPERIMENTAL
Intervention: Telmisartan with sodium chloride (NaCl) supplementation (100 mmol/24 h)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Telmisartan with placebo capsules
Number of subjects: 28
Study: 30415175

Group type: EXPERIMENTAL
Intervention: Olanzapine (OLZ) users
Number of subjects: 128

Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 128
Study: 27515875

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 374

Group type: COMPARATOR
Intervention: Control
Number of subjects: 374
Study: 24183325

Group type: EXPERIMENTAL
Intervention: Gap balancing
Number of subjects: 103

Group type: COMPARATOR
Intervention: Measured resection
Number of subjects: 103
Study: 22489515

Group type: EXPERIMENTAL
Intervention: Blade needle closed loosing and reduction with traction
Number of subjects: 65

Group type: COMPARATOR
Intervention: Traditional traction
Number of subjects: 65
Study: 20096611

Group type: EXPERIMENTAL
Intervention: Endovascular aneurysm repair (EVAR)
Number of subjects: 404

Group type: COMPARATOR
Intervention: No surgical intervention (control)
Number of subjects: 404
Study: 18285411

Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg/d) for 16 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 15738497

Group type: EXPERIMENTAL
Intervention: Various interventions (over 700 evaluated)
Number of subjects: 28669
Study: 11944023

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (400 IU of vitamin E, 500 mg of vitamin C, and 12 mg of beta-carotene daily)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (800 IU of vitamin E, 1000 mg of vitamin C, and 24 mg of beta-carotene daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9743957

Group type: EXPERIMENTAL
Intervention: HIT'88/'89 regimen (preradiation chemotherapy)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Standard regimen (CCNU, cisplatin, and vincristine after radiation therapy)
Number of subjects: 147
Study: 8983939

Group type: EXPERIMENTAL
Intervention: Rifampicine Generic 300 mg capsules
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rimactan 300 mg capsules
Number of subjects: 12
Study: 2517005

Group type: EXPERIMENTAL
Intervention: Rilmenidine (1 mg once or twice daily)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459

Group type: COMPARATOR
Intervention: Clonidine (0.150 mg once or twice daily)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Rilmenidine (single dose)
Number of subjects: 459
Study: 782477

Group type: EXPERIMENTAL
Intervention: CN 3123 (sulfamoxole/trimethoprim)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference preparation
Number of subjects: 0
Study: 7325577

Group type: COMPARATOR
Intervention: 26-gauge needle
Number of subjects: 797

Group type: COMPARATOR
Intervention: 100 mg indomethacin administered six hours after blockade
Number of subjects: 797

Group type: COMPARATOR
Intervention: 3000 ml fluid infusion during operation
Number of subjects: 797

Group type: COMPARATOR
Intervention: Recumbency for 24 hours
Number of subjects: 797

Group type: COMPARATOR
Intervention: Prophylactic epidural blood patching
Number of subjects: 797
Study: 30839454

Group type: EXPERIMENTAL
Intervention: Communication intervention delivered by nurse interveners
Number of subjects: 12
Study: 27720812

Group type: EXPERIMENTAL
Intervention: Exercise plus trigger point dry needling (TrP‐DN)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 50
Study: 27785656

Group type: EXPERIMENTAL
Intervention: PATHS Curriculum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attentional control
Number of subjects: 0
Study: 25056584

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy with 300 index of reactivity mixture of Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for 12 months
Number of subjects: 484

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 484
Study: 22135048

Group type: EXPERIMENTAL
Intervention: Freeze-dried strawberry powder at 60 g/d
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Freeze-dried strawberry powder at 30 g/d
Number of subjects: 75
Study: 19462699

Group type: EXPERIMENTAL
Intervention: Cognitive impairment (CI) assessment using MMSE
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Moderate cognitive impairment (CI)
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Mild cognitive impairment (CI)
Number of subjects: 745
Study: 17224647

Group type: EXPERIMENTAL
Intervention: Celecoxib + Surgery
Number of subjects: 59

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 59

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 59
Study: 15199361

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/d)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (healthy postmenopausal women)
Number of subjects: 27
Study: 12530261

Group type: EXPERIMENTAL
Intervention: CHOP-Dexa-BEAM plus autologous hemopoietic cell transplantation
Number of subjects: 70

Group type: COMPARATOR
Intervention: CHOP-Dexa-BEAM
Number of subjects: 70

Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 70
Study: 9661605

Group type: EXPERIMENTAL
Intervention: Lipid (Liposyn II; 1.5 mL/min) and heparin (0.4 U/kg.min; L/H) infusion
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline/glycerol (2.25 g/h; S/G) infusion
Number of subjects: 7
Study: 7659838

Group type: EXPERIMENTAL
Intervention: Indomethacin (group 2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (group 1)
Number of subjects: 20
Study: 2745669

Group type: EXPERIMENTAL
Intervention: Bromocriptine administration during days 2-12 of ovarian hyperstimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 180193

Group type: EXPERIMENTAL
Intervention: SKF 40491
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GLR9‐338
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RP L9326
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31633607

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.4 mg/kg with volume adjusted to 0.2 mL/kg of 0.2% or 0.4 mL/kg of 0.1%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.4 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Levobupivacaine dosing regimen
Number of subjects: 40
Study: 30652510

Group type: EXPERIMENTAL
Intervention: Crizotinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 27415645

Group type: EXPERIMENTAL
Intervention: PRB exercises combined with motivational group discussions twice weekly for 3 months
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 67
Study: 26721137

Group type: EXPERIMENTAL
Intervention: Pricking blood combined with moxibustion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Western medication (0.3 g ibuprofen orally twice a day for 10 days)
Number of subjects: 40
Study: 23320605

Group type: EXPERIMENTAL
Intervention: Selenium at 0.15 mg kg(‐1)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Selenium at 0.30 mg kg(‐1)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Selenium at 0.45 mg kg(‐1)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control (0 mg kg(‐1) selenium)
Number of subjects: 360
Study: 21792049

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL) conversion
Number of subjects: 830

Group type: COMPARATOR
Intervention: CNI continuation
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: All other malignancies
Number of subjects: 830
Study: 19397687

Group type: EXPERIMENTAL
Intervention: Polymerized-Collagen (2 mL, 12 intra-articular injections over 6 months)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (2 mL, 12 intra-articular injections over 6 months)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Polymerized-Collagen and Placebo
Number of subjects: 53
Study: 17415541

Group type: EXPERIMENTAL
Intervention: Anterior access technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Posterior access technique
Number of subjects: 40
Study: 15127149

Group type: EXPERIMENTAL
Intervention: Constitutionally weak voices
Number of subjects: 33

Group type: COMPARATOR
Intervention: Normal vocal constitution
Number of subjects: 33
Study: 12067865

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg iv just prior to induction of anesthesia
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: acupressure wristbands applied at the P6 points
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no active intervention)
Number of subjects: 150
Study: 9619942

Group type: EXPERIMENTAL
Intervention: Unreamed titanium nails
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reamed nails
Number of subjects: 48
Study: 7653449

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 6595

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6595
Study: 2565682

Group type: EXPERIMENTAL
Intervention: Beta blockers
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 70931

Group type: EXPERIMENTAL
Intervention: Zinc sulphate, 0.6 g daily for 12 weeks (some patients treated for 4 or 8 weeks)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Zinc sulphate
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 31878319

Group type: EXPERIMENTAL
Intervention: Exergame intervention (24 weeks, 120 min/week, 2 sessions)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Detraining (24 weeks after intervention)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 55
Study: 28055119

Group type: EXPERIMENTAL
Intervention: Attention and Interpretation Modification for Fear of Breast Cancer Recurrence (AIM‐FBCR)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control condition program
Number of subjects: 110
Study: 30930573

Group type: EXPERIMENTAL
Intervention: Ultrasound phonophoresis therapy with Lofnac Gel (diclofenac and methyl salicylate)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ultrasound with water as coupling medium
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ultrasound phonophoresis therapy with Lofnac Gel
Number of subjects: 70
Study: 24279128

Group type: EXPERIMENTAL
Intervention: Medical mathematics bridge and tutoring programs
Number of subjects: 105

Group type: COMPARATOR
Intervention: Previous years without intervention
Number of subjects: 105
Study: 21136267

Group type: EXPERIMENTAL
Intervention: Intra-umbilical oxytocin 100 IU diluted in 30 ml of saline
Number of subjects: 61

Group type: COMPARATOR
Intervention: Controlled cord traction only
Number of subjects: 61
Study: 19075284

Group type: EXPERIMENTAL
Intervention: Low-fat diet high in vegetables, fruit, and fiber
Number of subjects: 2967

Group type: COMPARATOR
Intervention: Five-a-day dietary guidelines (Control)
Number of subjects: 2967
Study: 17509436

Group type: EXPERIMENTAL
Intervention: Trendelenburg test
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Active Straight Leg Raise (ASLR) test
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Breathing pattern during ASLR
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Trendelenburg test and ASLR tests
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Trendelenburg test, ASLR test, and breathing pattern assessment
Number of subjects: 36
Study: 15492460

Group type: EXPERIMENTAL
Intervention: Tussah silk-processing workers
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control workers
Number of subjects: 197
Study: 11676979

Group type: EXPERIMENTAL
Intervention: HPV-16 DNA detection in cervical carcinoma
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Spontaneous apoptosis analysis in cervical carcinoma
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: TNF-alpha quantification in cervical carcinoma
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Correlation of TNF-alpha with apoptosis
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cut-off value for TNF-alpha
Number of subjects: 50
Study: 9338642

Group type: EXPERIMENTAL
Intervention: Pulsatile flow at pump flow rates of 0.6, 1.2, and 2.4 L x m2 x min(‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonpulsatile flow at pump flow rates of 0.6, 1.2, and 2.4 L x m2 x min(‐1)
Number of subjects: 40
Study: 8433024

Group type: EXPERIMENTAL
Intervention: Endocavitary hyperthermia combined with 10 MeV X-ray or 60CO (group A)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Preoperative radiation (group B)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Surgery (group C)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 40 Gy plus heat
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 40 Gy alone
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 30 Gy plus heat
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 30 Gy alone
Number of subjects: 122
Study: 3318993

Group type: EXPERIMENTAL
Intervention: 10 mg rimexolone
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: 20 mg rimexolone
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: 40 mg rimexolone
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 31596969

Group type: EXPERIMENTAL
Intervention: Quality of collaboration within the partnership
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Sense of community responsibility
Number of subjects: 238
Study: 30025006

Group type: EXPERIMENTAL
Intervention: Autologous block
Number of subjects: 8

Group type: COMPARATOR
Intervention: Xenogeneic block
Number of subjects: 8
Study: 27601891

Group type: EXPERIMENTAL
Intervention: FreeO2
Number of subjects: 50

Group type: COMPARATOR
Intervention: Manual oxygen titration
Number of subjects: 50
Study: 25059747

Group type: EXPERIMENTAL
Intervention: Operative treatment (open reduction and internal fixation)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 151
Study: 21898023

Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open colectomy (group A)
Number of subjects: 40
Study: 21258131

Group type: EXPERIMENTAL
Intervention: Systematic screening
Number of subjects: 42376

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 42376
Study: 18076224

Group type: EXPERIMENTAL
Intervention: Blocked multiple-set regimen
Number of subjects: 42

Group type: COMPARATOR
Intervention: Single-set regimen
Number of subjects: 42